Literature DB >> 10498208

Protein kinase C modulators bearing dicarba-CLOSO-dodecaborane as a hydrophobic pharmacophore.

Y Endo1, T Yoshimi, K Kimura, A Itai.   

Abstract

The size and position of a hydrophobic moiety on a benzolactam skeleton, which reproduces the active conformation and biological activity of teleocidins, play an important role in the appearance of the activity. We have designed and synthesized benzolactams bearing dicarba-closo-dodecaborane. These compounds showed potent binding affinity to protein kinase C, providing a further example of the application of carborane as the hydrophobic pharmacophore of biologically active molecules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10498208     DOI: 10.1016/s0960-894x(99)00436-9

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

1.  From nonpeptide toward noncarbon protease inhibitors: metallacarboranes as specific and potent inhibitors of HIV protease.

Authors:  Petr Cígler; Milan Kozísek; Pavlína Rezácová; Jírí Brynda; Zbyszek Otwinowski; Jana Pokorná; Jaromír Plesek; Bohumír Grüner; Lucie Dolecková-Maresová; Martin Mása; Juraj Sedlácek; Jochen Bodem; Hans-Georg Kräusslich; Vladimír Král; Jan Konvalinka
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-14       Impact factor: 11.205

2.  Synthesis and evaluation of carbaborane derivatives of indomethacin as cyclooxygenase inhibitors.

Authors:  Matthias Scholz; Anna L Blobaum; Lawrence J Marnett; Evamarie Hey-Hawkins
Journal:  Bioorg Med Chem       Date:  2011-03-27       Impact factor: 3.641

3.  Carborane clusters in computational drug design: a comparative docking evaluation using AutoDock, FlexX, Glide, and Surflex.

Authors:  Rohit Tiwari; Kiran Mahasenan; Ryan Pavlovicz; Chenglong Li; Werner Tjarks
Journal:  J Chem Inf Model       Date:  2009-06       Impact factor: 4.956

4.  Nitric oxide synthases activation and inhibition by metallacarborane-cluster-based isoform-specific affectors.

Authors:  Robert Kaplánek; Pavel Martásek; Bohumír Grüner; Satya Panda; Jakub Rak; Bettie Sue Siler Masters; Vladimír Král; Linda J Roman
Journal:  J Med Chem       Date:  2012-11-01       Impact factor: 7.446

5.  Utilization of Boron Compounds for the Modification of Suberoyl Anilide Hydroxamic Acid as Inhibitor of Histone Deacetylase Class II Homo sapiens.

Authors:  Ridla Bakri; Arli Aditya Parikesit; Cipta Prio Satriyanto; Djati Kerami; Usman Sumo Friend Tambunan
Journal:  Adv Bioinformatics       Date:  2014-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.